Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 10/20 | 0.63 |
| ▸ | MAPT | P10636 | 4/20 | 0.60 |
| ▸ | MEN1 | O00255 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.60 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.60 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3489324 | 0.92 | FTO (0.59) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL7971505 | 0.85 | FTO (0.45) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL27637121 | 0.83 | FTO (0.65) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL20073857 | 0.82 | FTO (0.67) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL21111082 | 0.82 | FTO (0.60) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL27833470 | 0.81 | FTO (0.83) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL29995323 | 0.80 | FTO (0.70) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL15059064 | 0.80 | FTO (0.70) | FTOMAPTMEN1KMT2AHPGD | |
| Fluorescein SCHEMBL3508466 | 0.79 | FTO (0.89) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL7030299 | 0.79 | FTO (0.53) | FTOMAPTMEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101050358-A | Method for preparing dyestuff controllable doped Nano particles of silicon dioxide | UNIV JILIN (CN) | 2007-10-10 | — | — | CN | claimed |
| US-12460271-B2 | Method for detecting specific DNA in a sample | C4U CORPORATION (JP) | 2025-11-04 | — | — | US | disclosed |
| US-20230099483-A1 | METHOD FOR DETECTING SPECIFIC DNA IN SAMPLE | C4U CORPORATION (JP) | 2023-03-30 | — | — | US | disclosed |
| EP-4095245-A1 | METHOD FOR DETECTING SPECIFIC DNA IN SAMPLE | C4U Corporation (JP) | 2022-11-30 | — | — | EP | disclosed |
| US-20190145985-A1 | METHOD FOR ELIMINATING TARGET INTERFERENCE | BioAgilytix Labs, LLC | 2019-05-16 | — | — | US | disclosed |
| CN-106457090-A | Method for the quantification of parasite eggs in feces | MEP马解决方案有限责任公司 | 2017-02-22 | — | — | CN | disclosed |
| US-9284381-B2 | Methods and reagents for preparing multifunctional probes | THE GENERAL HOSPITAL CORPORATION (US) | 2016-03-15 | — | — | US | disclosed |
| US-20130295640-A1 | Methods and Reagents for Preparing Multifunctional Probes | JOSEPHSON LEE (US) | 2013-11-07 | — | — | US | disclosed |
| US-8546531-B2 | Methods and reagents for preparing multifunctional probes | THE GENERAL HOSPITAL CORPORATION (US) | 2013-10-01 | — | — | US | disclosed |
| US-20110159566-A1 | Methods and Reagents for Preparing Multifunctional Probes | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-06-30 | — | — | US | disclosed |
| US-20020094539-A1 | Methods and reagents for analysis of RNA structure and function | HORNBY DAVID P (GB) | 2002-07-18 | — | — | US | disclosed |
| US-20020086291-A1 | Methods and reagents for analysis of rna structure and function | TRANSGENOMIC, INC. | 2002-07-04 | — | — | US | disclosed |
| US-20020022224-A1 | Method for isolating single-stranded DNA | TRANSGENOMIC, INC. | 2002-02-21 | — | — | US | disclosed |
| WO-2001081566-A2 | APPARATUS AND METHOD FOR SEPARATING AND PURIFYING POLYNUCLEOTIDES | TRANSGENOMIC, INC. (US) | 2001-11-01 | — | — | WO | disclosed |
| EP-0294524-B1 | Real time scanning electrophoresis apparatus for DNA sequencing | PERKIN ELMER CORP (US) | 1997-11-26 | — | — | EP | disclosed |
| EP-0233053-B1 | Method of detecting electrophoretically separated oligonucleotides | APPLIED BIOSYSTEMS (US) | 1994-06-01 | — | — | EP | disclosed |
| US-4855225-A | LABELING WITH FLUORESCENT OR RHODANINE DYES | APPLIED BIOSYSTEMS, INC. (US) | 1989-08-08 | — | — | US | disclosed |
| US-4811218-A | Real time scanning electrophoresis apparatus for DNA sequencing | APPLIED BIOSYSTEMS, INC. (US) | 1989-03-07 | — | — | US | disclosed |
| EP-0294524-A1 | Real time scanning electrophoresis apparatus for DNA sequencing | THE PERKIN-ELMER CORPORATION (US) | 1988-12-14 | — | — | EP | disclosed |
| EP-0233053-A2 | Method of detecting electrophoretically separated oligonucleotides | APPLIED BIOSYSTEMS, INC. (US) | 1987-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110159566-A1 | Methods and Reagents for Preparing Multifunctional Probes | LNPEP, MSN, PDAP1 | FTO 3289/4885MAPT 862/4885MEN1 292/4885 |
| US-20130295640-A1 | Methods and Reagents for Preparing Multifunctional Probes | LNPEP, PDAP1, MSN | FTO 3356/4885MAPT 687/4885MEN1 324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.